We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXLA
3176
DELISTED
Axcella Health Inc. Common Stock
AXLA
$871K ﹤0.01%
6,304
+4,636
+278% +$567K
CALB
3177
DELISTED
California BanCorp Common Stock
CALB
$865K ﹤0.01%
+58,092
New +$842K
ET icon
3178
Energy Transfer Partners
ET
$70.1B
$863K ﹤0.01%
121,264
-989
-0.8% -$7.33K
LIQT icon
3179
LiqTech
LIQT
$23M
$863K ﹤0.01%
19,772
-254
-1% -$10.6K
SBT
3180
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$863K ﹤0.01%
241,090
-3,375
-1% -$11.1K
CSPR
3181
DELISTED
Casper Sleep Inc.
CSPR
$855K ﹤0.01%
95,368
+54,610
+134% +$387K
HOLI
3182
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$854K ﹤0.01%
64,294
+443
+0.7% +$6.02K
CRC
3183
DELISTED
California Resources Corporation
CRC
$848K ﹤0.01%
695,626
+22,947
+3% +$38.8K
CGEN icon
3184
Compugen
CGEN
$222M
$846K ﹤0.01%
56,355
+19,500
+53% +$263K
QADB
3185
DELISTED
QAD Inc. Class B
QADB
$846K ﹤0.01%
28,213
-452
-2% -$13.3K
DS
3186
DELISTED
Drive Shack Inc.
DS
$844K ﹤0.01%
456,339
-363,512
-44% -$597K
TEUM
3187
DELISTED
Pareteum Corporation
TEUM
$843K ﹤0.01%
1,359,774
-713,634
-34% -$394K
TELA icon
3188
TELA Bio
TELA
$32.7M
$841K ﹤0.01%
64,967
+34,767
+115% +$457K
MTNB icon
3189
Matinas BioPharma
MTNB
$1.88M
$834K ﹤0.01%
21,588
GBL
3190
DELISTED
GAMCO Investors, Inc.
GBL
$834K ﹤0.01%
62,682
+3,364
+6% +$41.9K
GDP
3191
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$833K ﹤0.01%
115,699
-1,438
-1% -$10.1K
ARD
3192
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$828K ﹤0.01%
64,177
-1,629
-2% -$20.3K
SAL
3193
DELISTED
Salisbury Bancorp, Inc.
SAL
$827K ﹤0.01%
+40,364
New +$732K
SLNO
3194
DELISTED
Soleno Therapeutics
SLNO
$816K ﹤0.01%
24,525
+15,181
+162% +$658K
PRGX
3195
DELISTED
PRGX Global, Inc.
PRGX
$815K ﹤0.01%
173,548
-106,767
-38% -$383K
CBNK icon
3196
Capital Bancorp
CBNK
$608M
$810K ﹤0.01%
75,740
+2,939
+4% +$31.8K
BCS icon
3197
Barclays
BCS
$92.7B
$806K ﹤0.01%
142,433
+8,092
+6% +$42.2K
PCVX icon
3198
Vaxcyte
PCVX
$7.81B
$806K ﹤0.01%
+25,526
New +$821K
INDY icon
3199
iShares S&P India Nifty 50 Index Fund
INDY
$562M
0
PTN
3200
Palatin Technologies
PTN
$13.7M
$805K ﹤0.01%
1,259
-1,039
-45% -$646K

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.